BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 31635993)

  • 21. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
    Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
    PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
    Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and functional role of miR-29b in renal cell carcinoma.
    Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
    Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
    Zhao X; Zhao Z; Xu W; Hou J; Du X
    Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
    Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
    Xiao W; Wang X; Wang T; Xing J
    Cancer Gene Ther; 2020 May; 27(5):330-340. PubMed ID: 31155610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
    Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
    Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
    Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-210 is a prognostic marker in clear cell renal cell carcinoma.
    Samaan S; Khella HW; Girgis A; Scorilas A; Lianidou E; Gabril M; Krylov SN; Jewett M; Bjarnason GA; El-said H; Yousef GM
    J Mol Diagn; 2015 Mar; 17(2):136-44. PubMed ID: 25555365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.
    Gowrishankar B; Ibragimova I; Zhou Y; Slifker MJ; Devarajan K; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Biol Ther; 2014 Mar; 15(3):329-41. PubMed ID: 24351440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
    Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
    Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    Fu Q; Liu Z; Pan D; Zhang W; Xu L; Zhu Y; Liu H; Xu J
    Cancer Sci; 2014 Nov; 105(11):1427-34. PubMed ID: 25155155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
    Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
    EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.